Base Year
Historical Year
Forecast Year
The growth of the global IgA nephropathy treatment market is being driven by the rising prevalence of the disease, which is currently rising at a growth rate of 0.02%. The prevalence is likely to grow further in the forecast period with the rising diagnosis of the disease.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
IgA nephropathy, also known as Berger's disease, is a chronic kidney disorder that happens when the deposits of an antibody, known as immunoglobulin A (IgA), starts building up in the kidneys. Immunoglobulin A (IgA) is an antibody, a protein, which is produced by the immune system to fight any foreign substances like bacteria and virus that can cause infections. When these IgA deposits start building up in the kidney, leads to inflammation that can even damage the functioning of the kidney. In this condition, the kidneys are unable to filter the waste, and this can lead to severe renal disorders after a while. The disease takes long to progress, an average of 10 to 20 years, however it can vary from person to person.
While the exact cause of the disorder continues to be ambiguous, some of the possible causes of the diseases can include genes, liver ailments like cirrhosis, hepatitis B and hepatitis C infections, celiac disease, and several other infections like HIV and bacterial infections.
The condition, if not taken care of, can lead to complications like high blood pressure, high cholesterol, acute kidney failure, nephrotic syndrome, cardiovascular disorders, and other chronic kidney disorders.
The disease does not cause obvious signs and symptoms in the beginning, which is why it is mostly not diagnosed in the initial stages even for decades. It is mostly diagnosed when the protein and red blood cells in the urine are detected to be higher than normal. The most common diagnostic methods to detect the condition include checking the medical history of the patient and their family, physical test, urine test, and blood test, among others. The signs and symptoms of the condition can include the presence of blood in urine or brownish urine, foamy urine due to the higher presence of protein, pain in the lower part of the ribs in the back, swollen hands and feet, high blood pressure, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market can be categorised into segments like diagnostic methods, treatment method, disease type, symptoms, age group, route of administration, treatment channel, distribution channel of drugs, end-user, and major regional markets.
Market Breakup by Diagnosis Method
Market Breakup by Treatment Method
Market Breakup by Disease Type
Market Breakup by Symptoms
Market Breakup by Age Group
Market Breakup by Route of Administration
IgA Nephropathy Treatment Market Breakup by Treatment Channel
Market Breakup by Distribution Channel of Drugs
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for IgA nephropathy treatment has been witnessing robust growth during the historical period due to the rise in the prevalence of chronic kidney disorders, technological advancements in the treatment sector, and the increasing demand for timely diagnosis of the disease. The Asia Pacific region is anticipated to witness significant demand over the forecast period as the prevalence of kidney disorder is rising at an alarming rate. The rising awareness about the condition, growth in the number of diagnostic techniques, as well as the rising approval od advanced and effective drugs is also propelling the growth of the market.
Within the Asia Pacific region, Japan and China are anticipated to be the leading contributors to the rising demand owing to the rising kidney cancer cases and the rapidly growing pharmaceutical sector in these countries.
This condition is most likely to occur to people suffering from diabetes or high blood pressure. The condition can happen at any age but is more common between teenagers and middle-aged people. Men are more likely to suffer from this disease, the chances are almost double. Based on region, it is more common amongst people belonging to Asian and European origins.
There is no absolute cure for the disease yet, but the treatments and therapies available in the market can help prevent the further progression of the disease and also help relieve the current symptoms. These treatments can be as follows:
Regulating food habits plays a pivotal role in controlling the symptoms of this condition and the patient must be extremely cautious of the food choices they make in order to prevent any further damage.
The report gives an in-depth analysis of the key players involved in the IgA nephropathy treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Diagnosis Method |
|
| Breakup by Treatment Method |
|
| Breakup by Disease Type |
|
| Breakup by Symptoms |
|
| Breakup by Age Group |
|
| Breakup by Route of Administration |
|
| Breakup by Treatment Channel |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The prevalence of the disease is likely to rise at a growth rate of more than 0.02% during the forecast period owing to the rising awareness.
The growth of the market is driven by factors like rising awareness about the disease, growing technological advancements, poor eating habits, and rising lifestyle disorders.
The rising drug and treatment approvals act as key trends for the market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The diagnosis methods used for the condition include blood test, urine test, kidney biopsy, ad iothalamate clearance test, among others.
The treatment methods used in the market include the use of corticosteroid drugs, immunosuppressive drugs, ACE inhibitors and ARBs, among others.
The condition, on the basis of type, can be categorised into primary and secondary IgA nephropathy.
The major symptoms include haematuria, proteinuria, and oedema, among others.
Anyone can suffer from this condition, including adults and children.
The routes of administration include oral and parenteral, among other methods.
The leading distribution channels for drugs include hospital pharmacy, retail pharmacy, online pharmacy, and direct tender, among others.
The end-use sectors include hospitals, clinics, and home healthcare, among others.
The treatment channels in the market include public and private, among others.
The key players in the market include Novartis AG, Calliditas Therapeutics AB, Chinook Therapeutics Inc., Travere Therapeutics Inc., Omeros Corporation, VIFOR Pharma, Vera Therapeutics Inc., Merck KGaA, Reata Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Apellis Pharmaceuticals Inc., and Otsuka Pharmaceutical Co. Ltd, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share